Catalent | Srodki Pieniężne I Ekwiwalent



Srodki Pieniężne I Ekwiwalent Zmiana Data
Agilent USD 1.79B 254M 2025-09
AstraZeneca USD 8.14B 1.08B 2025-09
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Bruker USD 293.1M 201.1M 2025-09
Centene USD 17.89B 830M 2025-12
Charles River Laboratories USD 207.1M 24.27M 2025-09
Cigna USD 6.02B 1.7B 2025-09
Danaher USD 4.62B 3.09B 2025-12
Dentsply International USD 363M 4M 2025-09
Elevance Health USD 9.49B 778M 2025-12
Eli Lilly USD 7.27B 2.52B 2025-12
Glaxosmithkline GBP 3.3B 303M 2025-09
Hologic USD 2.17B 208.5M 2025-12
Humana USD 4.2B 1.19B 2025-12
Illumina USD 1.42B 368M 2025-12
Intuitive Surgical USD 9.03B 601.6M 2025-12
IQVIA Holdings USD 1.98B 166M 2025-12
J&J USD 19.71B 1.48B 2025-12
Laboratory Of America USD 598.1M 49.2M 2025-09
Lonza CHF 1.11B 286M 2024-12
McKesson USD 2.96B 1.05B 2025-12
Merck EUR 1.17B 161M 2025-06
Merck USD 18.17B 10.16B 2025-09
Mettler Toledo International USD 69.06M 7.24M 2025-09
Novartis USD 9.56B 2.9B 2025-09
Pfizer USD 1.34B 295M 2025-09
Quest Diagnostics USD 420M 12M 2025-12
Repligen USD 748.75M 39.89M 2025-09
Revvity USD 919.86M 11.53M 2025-12
Roche Holding CHF 7.55B 579M 2025-06
Supernus Pharmaceuticals USD 151.37M 6.66M 2025-09
Thermo Fisher Scientific USD 9.85B 7.87B 2025-12
UnitedHealth USD 28.12B 2.49B 2025-12
Waters USD 587.83M 128.71M 2025-12
West Pharmaceutical Services USD 791.3M 162.8M 2025-12


Catalent Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.